For the Culture By The Culture. ISSN: 3064-9331.
For decades, federal policy claimed cannabis had no accepted medical use while opioid prescriptions moved through the health care system by the tens of millions. Cannabis Lies Vol. 10 exposes the contradiction behind Schedule I, blocked research, medical cannabis patients, and the institutions that spent years pretending politics was medicine.
Jersey reinvented itself. A forty-five square mile island once known for offshore finance is now exporting pharmaceutical-grade cannabis into Germany’s booming medical market. With strict regulation, heavy investment, and a government eager for diversification, Jersey has become an unlikely European powerhouse. The contradiction between local policing and global commerce tells the real story.
Australia’s medical cannabis system expanded rapidly through telehealth and high-volume prescribing. Now regulators are tightening oversight. The TGA and AHPRA are increasing scrutiny on prescribing practices, signaling a shift from rapid patient access toward stricter clinical control that could reshape how doctors prescribe and how patients obtain treatment.
Cannabis and mental health risks are often overstated in public debate. Research shows heavy use and high THC exposure can increase psychosis risk in vulnerable individuals, but widespread claims of a mental health crisis lack strong evidence. This piece examines the data, separates correlation from causation, and breaks down what cannabis users need to know.
Idaho lawmakers passed a resolution urging voters to reject a medical cannabis initiative before it reaches the ballot. The move highlights how officials are shaping public opinion ahead of a vote, while maintaining strict prohibition and blocking even limited access for patients.
Mississippi maintains strict limits on medical cannabis after Governor Tate Reeves vetoed expansion bills on March 26, 2026. Patients remain unable to use cannabis in hospitals while eligibility and access rules stay tightly controlled. This feature examines what the veto blocks, how it affects patients, and what it means for the state’s growing cannabis market.
